Elmiron is a popular anticoagulant that is commonly prescribed to treat bladder pain caused by interstitial cystitis and osteoarthritis. Recently, Elmiron has been linked to the increased risk of pigmentary maculopathy and other forms of vision loss and damage. The pharmaceutical liability attorneys at Peter Angelos P.C. Law are actively investigating cases regarding the use of Elmiron and can provide you skilled legal representation if you have suffered eye damage as a result of taking Elmiron. Learn more about the side effects of Elmiron below as well as legal action available to you.
Elmiron Use is Linked to Eye Damage
Elmiron (pentosan polysulfate sodium) is a weak blood thinner that is often prescribed as a bladder protectant used to treat interstitial cystitis and other bladder problems. It is the only FDA-approved drug used to treat interstitial cystitis, which causes chronic bladder pain in more than one million people in the U.S.
New research suggests that Elmiron use is linked to vision loss and other vision complications including pigmentary maculopathy and retinal damage. Pigmentary maculopathy is a degenerative eye disease that can lead to permanent vision loss. If you experienced any of these symptoms after taking Elmiron, contact your doctor immediately:
- Blurred vision
- Difficulty reading
- Dark spots
- Partial vision loss
- Loss of nighttime vision
- Blindness, and
- Other forms of vision impairment
Contact Peter Angelos P.C. Law If You Suffered Eye Damage After Taking Elmiron
If you or a loved one suffered vision loss after taking bladder drug Elmiron, we urge you to contact our team of pharmaceutical liability and defective drug attorneys today. Vision loss can be severely life-altering and victims who suffer eye damage after taking pharmaceutical drug Elmiron deserve to be duly compensated for their pain and suffering. Contact our Baltimore office today for a free consultation